Template:Neonatal conjunctivitis treatment: Difference between revisions
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
*Topical treatment is unnecessary | *Topical treatment is unnecessary | ||
===[[Herpetic]]=== | ===[[Herpetic|Herpes]]=== | ||
*Acyclovir 20mg/kg IV q8hr x 14-21d | *Acyclovir 20mg/kg IV q8hr x 14-21d | ||
*Topical antiviral | *Topical antiviral | ||
*Full sepsis evaluation | *Full sepsis evaluation | ||
===Chemical=== | |||
*Watchful waiting | |||
Revision as of 20:12, 20 May 2015
Gonococcal
- Cefotaxime 100mg/kg IV or IM OR ceftriaxone 25-50mg/kg IV or IM x1 (not to exceed 125mg)
- Cefotaxime is preferred because it does not displace bilirubin
- Disseminated disease should be suspected until CSF is negative
- Topical treatment is unnecessary
Chlamydia
- Azithromycin 20mg/kg PO once daily x 3 days OR
- Erythromycin 50mg/kg PO QD in 4 divided doses x 14 days
- Disease manifests 5 days post-birth to 2 weeks (late onset)
- Topical treatment is unnecessary
Herpes
- Acyclovir 20mg/kg IV q8hr x 14-21d
- Topical antiviral
- Full sepsis evaluation
Chemical
- Watchful waiting